Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826904 · ClinicalTrials.gov registry record
Regulation Of Maternal Fuel Supply And Neonatal Adiposity
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 59
- Enrollment target
NCT00826904: Completed study, sponsored by University of Colorado, Denver.
NCT00826904 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00826904 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether unrecognized maternal hyperglycemia and postprandial lipemia early or late in gestation predicts excess neonatal adiposity.
Primary Outcome
Prediction of neonatal adiposity by maternal Triglycerides and Glucose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2007-10 |
| Est. Completion | 2017-03-20 |
What the finished NCT00826904 record still lists
NCT00826904 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00826904 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00826904 about?
NCT00826904 is a clinical study titled "Regulation Of Maternal Fuel Supply And Neonatal Adiposity". The purpose of this study is to determine whether unrecognized maternal hyperglycemia and postprandial lipemia early or late in gestation predicts excess neonatal adiposity.
What is the current status of trial NCT00826904?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2007-10. Estimated completion is 2017-03-20.
Who is sponsoring clinical trial NCT00826904?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia